Northern Trust’s IGC Pharma IGC Stock Holding History

Northern Trust’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.3K	Buy	170,274 +56,867	+50%	+$16.8K	﹤0.01%	4276
2026 Q1	$29.8K	Hold	113,407	–	–	﹤0.01%	4305
2025 Q4	$31.9K	Hold	113,407	–	–	﹤0.01%	4343
2025 Q3	$47.3K	Hold	113,407	–	–	﹤0.01%	4291
2025 Q2	$34.7K	Hold	113,407	–	–	﹤0.01%	4289
2025 Q1	$32.3K	Hold	113,407	–	–	﹤0.01%	4290
2024 Q4	$38.1K	Buy	113,407 +42,380	+60%	+$15.9K	﹤0.01%	4298
2024 Q3	$30.3K	Hold	71,027	–	–	﹤0.01%	4283
2024 Q2	$30.8K	Sell	71,027 -337	-0.5%	-$168	﹤0.01%	4282
2024 Q1	$28.5K	Hold	71,364	–	–	﹤0.01%	4299
2023 Q4	$20K	Hold	71,364	–	–	﹤0.01%	4365
2023 Q3	$25.6K	Hold	71,364	–	–	﹤0.01%	4286
2023 Q2	$22.2K	Hold	71,364	–	–	﹤0.01%	4389
2023 Q1	$24.2K	Buy	71,364 +8,036	+13%	+$3.01K	﹤0.01%	4412
2022 Q4	$20.1K	Hold	63,328	–	–	﹤0.01%	4486
2022 Q3	$27K	Hold	63,328	–	–	﹤0.01%	4485
2022 Q2	$34K	Hold	63,328	–	–	﹤0.01%	4524
2022 Q1	$60K	Hold	63,328	–	–	﹤0.01%	4494
2021 Q4	$62K	Hold	63,328	–	–	﹤0.01%	4553
2021 Q3	$94K	Hold	63,328	–	–	﹤0.01%	4417
2021 Q2	$104K	Hold	63,328	–	–	﹤0.01%	4355
2021 Q1	$113K	Buy	63,328 +337	+0.5%	+$612	﹤0.01%	4258
2020 Q4	$98K	Sell	62,991 -21,542	-25%	-$31.8K	﹤0.01%	4117
2020 Q3	$88K	Sell	84,533 -5,523	-6%	-$5.61K	﹤0.01%	3990
2020 Q2	$54K	Sell	90,056 -3,541	-4%	-$1.92K	﹤0.01%	4047
2020 Q1	$46K	Hold	93,597	–	–	﹤0.01%	3967
2019 Q4	$59K	Hold	93,597	–	–	﹤0.01%	4027
2019 Q3	$91K	Buy	93,597 +52,318	+127%	+$63K	﹤0.01%	3938
2019 Q2	$68K	Buy	+41,279	New	+$58.3K	﹤0.01%	4030

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust's IGC Position: Q2 2026 in Review

Northern Trust increased its IGC Pharma (IGC) stake by 50% in Q2 2026, buying an estimated $16.8K and bringing the position to 170,274 shares worth $46.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4276.

Northern Trust first reported a position in IGC in Q2 2019 and has held it in 29 quarters since. The position peaked at $113K in Q1 2021. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

Northern Trust held 170,274 shares of IGC Pharma worth $46.3K as of Q2 2026.
Northern Trust bought 56,867 IGC Pharma shares in Q2 2026, an estimated $16.8K.
IGC Pharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4276 holding.
Northern Trust first reported a position in IGC Pharma in Q2 2019 and has held it in 29 quarters since.
Northern Trust's IGC Pharma position peaked at $113K in Q1 2021.
36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.